SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-18-009074
Filing Date
2018-04-25
Accepted
2018-04-25 16:58:47
Documents
5
Effectiveness Date
2018-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A tcon-defa14a_20171231.htm DEFA14A 42072
2 GRAPHIC g2018042516084109522500.jpg GRAPHIC 10766
3 GRAPHIC g2018042516084104322497.jpg GRAPHIC 40618
4 GRAPHIC g2018042516084106222498.jpg GRAPHIC 64770
5 GRAPHIC g2018042516084107922499.jpg GRAPHIC 19612
  Complete submission text file 0001564590-18-009074.txt   230814
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36818 | Film No.: 18775010
SIC: 2836 Biological Products, (No Diagnostic Substances)